Recent Content
DOAR Releases Results from a National Survey of Jurors’ Attitudes Toward Pharmaceutical Companies
May 14, 2024, New York, NY—DOAR, the nation’s leading trial consulting company, today released important findings from a new national study that examines several issues suspected of influencing jurors’ baseline attitudes toward pharmaceutical companies. The findings indicate that opinions of the pharmaceutical industry are generally favorable despite a prevailing view of it as profit-centric. The […]